FDG PET characterization of renal masses: Preliminary experience

Brain and Language

Volumn 52, Issue 7, 1997, Pages 510-515

  Goldberg, M A ^a   Mayo Smith, W W ^a   Papanicolaou, N ^a   Fischman, A J ^a   Lee, M J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGING; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY TUMOR; MALE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOLID TUMOR;

EID: 23744482767     PISSN: 0093934X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0009-9260(97)80327-3     Document Type: Article

References (33)

1. Bosniak MA. The current radiologic approach to renal cysts. Radiology 1986;158:1-10.
2. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991;179:307-317.
3. Hartman DS, Aronson S, Frazer H. Current status of imaging indeterminate renal masses. Radiologic Clinics of North America 1991;29: 475-496.
4. Patronas NJ, Di Chiro G, Brooks RA et al. [18F] fluorodeoxyglucose and positron emission tomography in evaluation of radiation necrosis of the brain. Radiology 1982;144:885-889.
5. Patronas NJ, Di Chiro G, Kufta C et al. Prediction of survival in glioma patients by means of positron emission tomography. Journal of Neurosurgery 1985;62:816-822.
6. Di Chiro G, Oldfield E, Wright DC et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. American Journal of Neuroradiology 1987;8:1083-1091.
7. Doyle WK, Budinger TF, Valk PE et al. Differentiation of cerebral necrosis from tumor recurrence by [18F] FDG and [82] Rb positron emission tomography. Journal of Computer Assisted Tomography 1987;11:563-570.
8. Valk PE, Budinger TF, Levin VA et al. PET of malignant cerebral tumors after interstitial brachytherapy: demonstration of metabolic activity and correlation with clinical outcome. Journal of Neurosurgery 1988;69:830-838.
9. Kim CK, Alavi JB, Alavi A et al. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. Journal of Neurooncology 1991;10:85-91.
10. Coleman RE, Hoffman JM, Hanson MW et al. Clinical application of PET for the evaluation of brain tumors. Journal of Nuclear Medicine 1991;32:616-622.
11. Griffeth LK, Dehdashti F, McGuire AH et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992;182:185-194.
12. Okazumi S, Isono K, Enomoto K et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. Journal of Nuclear Medicine 1992;33:333-339.
13. Strauss LG, Conti PS. The applications of PET in clinical oncology. Journal of Nuclear Medicine 1991;32:623-648.
14. Strauss LG, Clorius JH, Schlag P et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-332.
15. Haberkorn U, Strauss LG, Dimitrakopoulou A et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. Journal of Nuclear Medicine 1991;32:1485-1490.
16. Ito K, Kato T, Tadokoro M et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992;182:549-552.
17. Okada J, Yoshikawa K, Imazeki K et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. Journal of Nuclear Medicine 1991;32:686-691.
18. Okada J, Yoshikawa K, Itami M et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. Journal of Nuclear Medicine 1992;33:325-329.
19. Gupta NC, Frank AR, Dewan NA et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-444.
20. Wahl RL, Cody RL, Hutchins GD et al. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-D-deoxyglucose. Radiology 1991; 179:765-770.
21. Adler LP, Blair HF, Makley JT et al. Non-invasive grading of musculoskeletal tumors using PET. Journal of Nuclear Medicine 1991;32:1508-1512.
22. Wahl RL, Harney J, Hutchins G et al. Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies. Journal of Urology 1991;146:1470-1474.
23. Rota-Kops E, Herzog H, Schmid A et al. Performance characteristics of an eight-ring whole body PET scanner. Journal of Computer Assisted Tomography 1990;14:437-445.
24. Harnacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using amino-polyether supported nucleophilic substitution. Journal of Nuclear Medicine 1987;27:235-238.
25. Woodard HQ, Gigler RE, Freed BGR. Expression of tissue isotope distribution (letter). Journal of Nuclear Medicine 1975;16:958-959.
26. Warburg O. The Metabolism of Tumors. New York: Richard R. Smith Inc., 1931;129-169.
27. Gallagher BM, Fowler JS, Gutterson NI et al. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. Journal of Nuclear Medicine 1978;19:1154-1161.
28. Som P, Atkins HL, Bandoypadhyay D et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose [18F]: non-toxic tracer for rapid tumor detection. Journal of Nuclear Medicine 1980;21:670-675.
29. Monakhov NK, Neistadt EL. Shaylovskii MM et al. Physiochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. Journal of the National Cancer Institute 1978;61:27-34.
30. Weber MJ, Nakamura KD, Salter DW. Molecular events leading to enhanced glucose transport in Rous sarcoma virus-transformed cells. Fed Proc 1984;43:2246-2250.
31. Lindholm P, Minn H, Leskinen-Kallio S et al. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. Journal of Nuclear Medicine 1993;34:1-6.
32. Choyke PL, Glenn GM, Walther MM et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. American Journal of Roentgenology 1992;159:1229-1234.
33. Tahara T, Ichiya Y, Kuwabara Y et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. Journal of Computer Assisted Tomography 1989;13:829-831.